“New CDC Data Shows Highly Effective RSV Vaccines Prevent Infant Hospitalizations”
- New RSV vaccine 90% effective at preventing infant hospitalizations AOL
- RSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter: CDC STAT
- Beyfortus Approved to Prevent RSV in Infants & Children Infectious Disease Special Edition
- AstraZeneca, Sanofi’s Beyfortus 90% Effective at Preventing RSV Hospitalizations: CDC BioSpace
- CDC says new treatment for infant RSV infections ‘highly effective’ in preventing hospitalization WSB Atlanta
You can read the full story here: “New CDC Data Shows Highly Effective RSV Vaccines Prevent Infant Hospitalizations” .